JESSICA HOWARD: Open Payments
NPI 1215473780 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 41 payments from 9 companies in 2025. Trend: 2023 $772 · 2024 $976 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 12 | $177 |
| ABBVIE INC. | 11 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $115 |
| Madrigal Pharmaceuticals | 3 | $104 |
| Janssen Biotech, Inc. | 3 | $71 |
| Celltrion USA Inc. | 2 | $50 |
| GENZYME CORPORATION | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: IBSRELA, REZDIFFRA, ENTYVIO, TREMFYA, DUPIXENT, RINVOQ, VEGZELMA, LINZESS.
Industry payments across AL — which companies pay providers there.
